InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

LENZ Therapeutics, Inc.

LENZ Clue Score42
United States Fiscal year ends December CIK 0001815776 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
29 Oct 2026
10% owner
Sell indirect
107,170
$3.36
$360.09K
Ra Capital Management, L.p.
29 Oct 2026
10% owner
Sell indirect
451,998
$3.36
$1.52M
Ra Capital Management, L.p.
29 Oct 2026
10% owner
Sell indirect
2,159,516
$3.36
$7.26M
Daniel R. Chevallard
27 Mar 2026
Chief Financial Officer
Buy
7,500
$8.57
$64.28K
Evert B. Schimmelpennink
27 Mar 2026
President, CEO and Secretary
Buy
28,089
$8.95
$251.41K
Jeffrey P. George
27 Mar 2026
Director
Buy
5,592
$8.92
$49.89K
Shawn Olsson
17 Nov 2025
Chief Commercial Officer
Sold after exercise
5,788
$26.37
$152.61K
Shawn Olsson
17 Nov 2025
Chief Commercial Officer
Sold after exercise
4,212
$25.74
$108.41K
Daniel R. Chevallard
7 Nov 2025
Chief Financial Officer
Buy
2,178
$22.76
$49.56K
Daniel R. Chevallard
7 Nov 2025
Chief Financial Officer
Buy
20
$22.71
$454.20
James W McCollum
7 Nov 2025
Director
Buy
10,500
$22.79
$239.28K

What was left out

Form 4 filings counted 19
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 10,000
History held since 28 Jun 2021